Jimeno, C. et al. 2018. The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes. Journal of the ASEAN Federation of Endocrine Societies. 33, 2 (Sep. 2018), 114.